Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Reprimands Scios on Natrecor Promotions
Link ID 654
Title FDA Reprimands Scios on Natrecor Promotions
Url http://www.medscape.com/viewarticle/565649?src=rss
Description The agency has asked the company to withdraw several promotional items for nesiritide because they "are not appropriate reminder labeling." Heartwire
Category Articles > Cardiology
Keywords
Date Nov 12, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. TRITON-TIMI 38: Prasugrel Lowers Events but Ups Bleeding vs Clopidogrel
  Prasugrel reduced ischemic events vs clopidogrel, but increased major (and fatal) bleeding in patients with acute coronary syndromes scheduled for percutaneous coronary intervention. Medscape Medical News
Category:   Articles > Cardiology


2. POISEd to Change the Guidelines on Perioperative Use of Beta Blockers?
  Hailed as a landmark, the POISE trial has nevertheless generated mixed results, with no clear indication as to who will benefit and who will be harmed by the perioperative use of beta-blockers. Medscape Medical News
Category:   Articles > Cardiology


3. Six-Month CACTUS Results: "No Advantage, No Penalization" in Using Two Stents for Bifurcations
  The trial, comparing the crush technique with provisional T-stenting in bifurcation lesions, suggests that outcomes are similar, regardless of the technique used, at least in "true" bifurcation lesions where both the main vessel and side branch have significant stenosis. Heartwire
Category:   Articles > Cardiology


4. Risk for Metabolic Syndrome Linked to Sleep Duration
  A study shows that in patients aged 30 to 54 years, abdominal obesity and elevated glucose are components of the metabolic syndrome most strongly associated with short sleep duration. Medscape Medical News
Category:   Articles > Cardiology


5. Intensive Atorvastatin Effective in CKD Patients and Also Reduces Second and Third Cardiovascular Ev
  One analysis showed that aggressive statin therapy reduced the risk of cardiovascular events in coronary heart disease patients with chronic kidney disease and diabetes, while another showed that high-dose statin therapy reduced not only first events but second and third cardiovascular events as well. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS